Text of UT HB 174 (2026)
Sex Characteristic Change Treatment Amendments
Legislative text is a public record. Where LegiScan supplied it, the CC BY 4.0 credit applies.
Source: LegiScan. Bill data and text from LegiScan (legiscan.com), licensed CC BY 4.0 and used in modified form. LegiScan does not endorse the Trans Data Initiative. License: CC BY 4.0(opens another site). Source page(opens another site)
As introduced
5,525 characters
01-07 13:12
H.B. 174
1
Sex Characteristic Change Treatment Amendments
2026 GENERAL SESSION
STATE OF UTAH
Chief Sponsor: Rex P. Shipp
Senate Sponsor:
2
3
LONG TITLE
4
General Description:
5
This bill amends provisions related to provision of cross-sex hormones and puberty
6
blockers to minors.
7
Highlighted Provisions:
8
This bill:
9
▸
prohibits providing cross-sex hormones and puberty blockers to minors unless certain
10
circumstances are met; and
11
▸
requires health care professionals providing cross-sex hormones or puberty blockers to
12
minors that will no longer continue to receive the cross-sex hormones and puberty
13
blockers to begin treatment plans for the discontinuation of the cross-sex hormones and
14
puberty blockers.
15
Money Appropriated in this Bill:
16
None
17
Other Special Clauses:
18
This bill provides a special effective date.
19
This bill provides revisor instructions.
20
Utah Code Sections Affected:
21
AMENDS:
22
58-1-603.1, as enacted by Laws of Utah 2023, Chapter 2 and further amended by Revisor
23
Instructions, Laws of Utah 2023, Chapter 2
24
REPEALS:
25
26B-1-239, as last amended by Laws of Utah 2024, Chapter 507
26
Utah Code Sections Affected by Revisor Instructions:
27
58-1-603.1, as enacted by Laws of Utah 2023, Chapter 2 and further amended by Revisor
28
Instructions, Laws of Utah 2023, Chapter 2
29
30
Be it enacted by the Legislature of the state of Utah:
H.B. 174
H.B. 174
01-07 13:12
31
The following section is affected by a revisor instruction at the end of this bill.
32
Section 1. Section 58-1-603.1 is amended to read:
33
58-1-603.1 . Hormonal transgender treatment prohibition for minors.
34
(1) As used in this section:
35
(a) "Cross-sex hormone treatment" means administering, prescribing, or supplying for
36
effectuating or facilitating an individual's attempted sex change:
37
(i) to an individual whose biological sex at birth is female, a dose of testosterone or
38
other androgens at levels above those normally found in an individual whose
39
biological sex at birth is female; or
40
(ii) to an individual whose biological sex at birth is male, a dose of estrogen or a
41
synthetic compound with estrogenic activity or effect at levels above those
42
normally found in an individual whose biological sex at birth is male.
43
(b) "Health care provider" means the same as that term is defined in Section 58-1-603.
44
[(b)] (c) "Hormonal transgender treatment" means the same as that term is defined in
45
Section 58-1-603.
46
(d) "Minor" means the same as that term is defined in Section 58-1-603.
47
(2) [A] Except as provided in Subsection (3), a health care provider may not provide a
48
hormonal transgender treatment to a patient who[:]
49
[(a)] is a minor[ as defined in Section 58-1-603; and] .
50
[(b) is not diagnosed with gender dysphoria before January 28, 2023.]
51
(3)(a) If a minor has received cross-sex hormone treatment before the effective date of
52
this bill, a health care provider may provide a cross-sex hormone treatment to a minor
53
only in accordance with Subsections (3)(b) and (c).
54
(b) A health care provider providing cross-sex hormone treatment to a minor who is
55
described in Subsection (3)(a) shall immediately begin a treatment plan to
56
progressively reduce cross-sex hormone dosages in order to discontinue any
57
cross-sex hormone treatment on or before six months after the effective date of this
58
bill.
59
(c) Notwithstanding Subsections (3)(a) and (b), a health care provider may continue to
60
provide cross-sex hormone treatment to a minor without a treatment plan described in
61
Subsection (3)(b) if:
62
(i) the minor's parent or guardian consents to continue treatment without a treatment
63
plan described in Subsection (3)(b); and
64
(ii)(A) the minor is at least 17 years old as of the effective date of this bill and will
- 2 -
01-07 13:12
H.B. 174
65
have received cross-sex hormone treatment for at least two years as of the
66
effective date of this bill; or
67
(B) will be 18 years old on or before six months after the effective date of this bill.
68
[(3)] (4) A violation of Subsection (2) is unprofessional conduct.
69
Section 2. Repealer.
70
This bill repeals:
71
Section 26B-1-239, Systematic medical evidence review of hormonal transgender
72
treatments.
73
Section 3. Effective Date.
74
This bill takes effect:
75
(1) except as provided in Subsection (2), May 6, 2026; or
76
(2) if approved by two-thirds of all members elected to each house:
77
(a) upon approval by the governor;
78
(b) without the governor's signature, the day following the constitutional time limit of
79
Utah Constitution, Article VII, Section 8; or
80
(c) in the case of a veto, the date of veto override.
81
Section 4. Revisor instructions.
82
The Legislature intends that the Office of Legislative Research and General Counsel, in
83
preparing the Utah Code database for publication, to revise Section 58-1-603.1 by replacing
84
each instance of the phrase:
85
(1) "the effective date of this bill" with the bill's actual effective date; and
86
(2) "six months after the effective date of this bill" with the date that is six months after the
87
effective date of this bill.
- 3 -
As enrolled or final
4,254 characters
Enrolled Copy
H.B. 174
1
Sex Characteristic Change Treatment Amendments
2026 GENERAL SESSION
STATE OF UTAH
Chief Sponsor: Rex P. Shipp
Senate Sponsor: Daniel McCay
2
3
LONG TITLE
4
General Description:
5
This bill amends provisions related to the provision of cross-sex hormones and puberty
6
blockers to minors.
7
Highlighted Provisions:
8
This bill:
9
▸
prohibits providing cross-sex hormones and puberty blockers to minors after a certain
10
date.
11
Money Appropriated in this Bill:
12
None
13
Other Special Clauses:
14
This bill provides a special effective date.
15
This bill provides revisor instructions.
16
Utah Code Sections Affected:
17
AMENDS:
18
58-1-603.1, as enacted by Laws of Utah 2023, Chapter 2 and further amended by Revisor
19
Instructions, Laws of Utah 2023, Chapter 2
20
REPEALS:
21
26B-1-239, as last amended by Laws of Utah 2024, Chapter 507
22
23
Be it enacted by the Legislature of the state of Utah:
24
The following section is affected by a revisor instruction at the end of this bill.
25
Section 1. Section 58-1-603.1 is amended to read:
26
58-1-603.1 . Hormonal transgender treatment prohibition for minors.
27
(1) As used in this section:
28
(a) "Cross-sex hormone treatment" means administering, prescribing, or supplying for
H.B. 174
Enrolled Copy
29
effectuating or facilitating an individual's attempted sex change:
30
(i) to an individual whose biological sex at birth is female, a dose of testosterone or
31
other androgens at levels above those normally found in an individual whose
32
biological sex at birth is female; or
33
(ii) to an individual whose biological sex at birth is male, a dose of estrogen or a
34
synthetic compound with estrogenic activity or effect at levels above those
35
normally found in an individual whose biological sex at birth is male.
36
(b) "Health care provider" means the same as that term is defined in Section 58-1-603.
37
[(b)] (c) "Hormonal transgender treatment" means the same as that term is defined in
38
Section 58-1-603.
39
(d) "Minor" means the same as that term is defined in Section 58-1-603.
40
(2) [A] Subject to Subsection (3), a health care provider may not provide a hormonal
41
transgender treatment to a patient who:
42
(a) is a minor[ as defined in Section 58-1-603]; and
43
(b) is not diagnosed with gender dysphoria before January 28, 2023.
44
(3) Notwithstanding Subsection 58-1-603(3)(a), beginning on January 28, 2027, a health
45
care provider may not provide a hormonal transgender treatment to a patient who is a
46
minor if the patient:
47
(a) would be younger than 16 years old as of the effective date of this bill; or
48
(b) has not received cross-sex hormones as of the effective date of this bill.
49
(4) A health care provider who provides hormonal transgender treatment to a minor for the
50
purpose of discontinuing treatment before January 28, 2027, may provide the treatment
51
without obtaining a transgender treatment certification described in Section 58-1-603.
52
[(3)] (5) A violation of Subsection (2) or (3) is unprofessional conduct.
53
Section 2. Repealer.
54
This bill repeals:
55
Section 26B-1-239, Systematic medical evidence review of hormonal transgender
56
treatments.
57
Section 3. Effective Date.
58
This bill takes effect:
59
(1) except as provided in Subsection (2), May 6, 2026; or
60
(2) if approved by two-thirds of all members elected to each house:
61
(a) upon approval by the governor;
62
(b) without the governor's signature, the day following the constitutional time limit of
- 2 -
Enrolled Copy
H.B. 174
63
Utah Constitution, Article VII, Section 8; or
64
(c) in the case of a veto, the date of veto override.
65
Section 4. Revisor instructions.
66
The Legislature intends that the Office of Legislative Research and General Counsel, in
67
preparing the Utah Code database for publication, to revise Section 58-1-603.1 by replacing
68
each instance of the phrase "the effective date of this bill" with the bill's actual effective date.
- 3 -